Edmund Nesti

Alcamena Stem Cell Therapeutics, Llc

$1,928,506

Attributed

$2,980,845

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY2018–25

$2M$1.5M$1M$500K$0

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,980,845 · 3

By mechanism

R44$1,500,000 · 1

R43$1,480,845 · 2

Top collaborators

Most similar at Alcamena Stem Cell Therapeutics, Llc

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Rattus”

John Damon Chodera · Sloan-Kettering Inst Can Research$33,543,727
Xinhua Li · Nano Terra, Inc.$23,579,188
Barney Sparrow · Battelle Memorial Institu$16,547,191
Vera Hoffman · Reveal Pharma$14,477,163
Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
Gonul Velicelebi · Sanford Burnham Prebys Medical Discovery Institute$8,970,452

Research focus

RattusDoseRandomizedCellsPermeabilityAffectInjuryPreventTissuesGenesNeuronsGene ExpressionPeptidesIn VivoIn VitroLibrariesMotorAffinityOverexpressionHealth SciencesMutantBindingExperimental StudyNatural Regeneration

Grant awards (5)

FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain$1,500,000

R44 · FY2025 · NS · contact PI

OPTIMIZATION AND ASSESSMENT OF A BIOLOGIC TO IMPROVE FUNCTIONAL RECOVERY AFTER PERIPHERAL NERVE INJURY$389,350

R43 · FY2020 · NS

OPTIMIZATION AND ASSESSMENT OF A BIOLOGIC TO IMPROVE COGNITIVE FUNCTION AFTER TRAUMATIC BRAIN INJURY$543,500

R43 · FY2019 · NS

OPTIMIZATION AND ASSESSMENT OF A BIOLOGIC TO IMPROVE FUNCTIONAL RECOVERY AFTER PERIPHERAL NERVE INJURY$310,191

R43 · FY2019 · NS

OPTIMIZATION AND ASSESSMENT OF A BIOLOGIC TO IMPROVE COGNITIVE FUNCTION AFTER TRAUMATIC BRAIN INJURY$237,804

R43 · FY2018 · NS